PortfoliosLab logo

Ascentage Pharma Grp International (6855.HK)

Equity · Currency in HKD · Last updated Jun 3, 2023

Company Info

ISINKYG0519B1023
SectorHealthcare
IndustryBiotechnology

Highlights

Market CapHK$6.07B
EPSHK$0.00
PE RatioN/A
PEG RatioN/A
Revenue (TTM)HK$209.71M
Gross Profit (TTM)HK$24.58M
EBITDA (TTM)-HK$835.99M
Year RangeHK$11.24 - HK$34.45
Target PriceHK$31.09

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of HK$10,000 in Ascentage Pharma Grp International, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%50.00%2023FebruaryMarchAprilMayJune
-3.87%
6.19%
6855.HK (Ascentage Pharma Grp International)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 6855.HK

Return

Ascentage Pharma Grp International had a return of -17.90% year-to-date (YTD) and 19.48% in the last 12 months. Over the past 10 years, Ascentage Pharma Grp International had an annualized return of -15.15%, while the S&P 500 had an annualized return of 9.67%, indicating that Ascentage Pharma Grp International did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-4.74%3.19%
Year-To-Date-17.90%9.50%
6 months0.48%4.00%
1 year19.48%-2.77%
5 years (annualized)-15.15%9.67%
10 years (annualized)-15.15%9.67%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202316.54%-16.69%-10.42%2.46%-10.92%
202240.52%17.08%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Ascentage Pharma Grp International (6855.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
6855.HK
Ascentage Pharma Grp International
0.74
^GSPC
S&P 500
0.21

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Ascentage Pharma Grp International Sharpe ratio is 0.74. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.002023FebruaryMarchAprilMayJune
0.74
0.10
6855.HK (Ascentage Pharma Grp International)
Benchmark (^GSPC)

Dividend History


Ascentage Pharma Grp International doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%2023FebruaryMarchAprilMayJune
-61.84%
-10.56%
6855.HK (Ascentage Pharma Grp International)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Ascentage Pharma Grp International. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Ascentage Pharma Grp International is 79.31%, recorded on Oct 7, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-79.31%Jul 23, 2021299Oct 7, 2022
-50.8%Jul 8, 202098Nov 26, 202040Jan 25, 2021138
-48.25%Nov 7, 201993Mar 23, 202057Jun 16, 2020150
-43.18%Jan 26, 202143Mar 29, 202171Jul 14, 2021114
-10.29%Jul 15, 20213Jul 19, 20212Jul 21, 20215

Volatility Chart

The current Ascentage Pharma Grp International volatility is 14.21%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%2023FebruaryMarchAprilMayJune
14.21%
3.64%
6855.HK (Ascentage Pharma Grp International)
Benchmark (^GSPC)